Cincinnati Enquirer speaks with UC College of Medicine researcher about opioids and HIV
Jason Blackard, PhD, uses NIDA grant to find better therapies for addicts living with HIV
The Cincinnati Enquirer highlighted a $1.7 million National Institute of Drug Abuse (NIDA) grant awarded over a three-year period to Jason Blackard, PhD, to conduct an omics analysis of synthetic opioids and HIV. Blackard, an associate professor in the UC Department of Internal Medicine’s Division of Digestive Diseases, says opioids and HIV encourage one another and not in a good way.
Jennifer Brown, PhD, associate professor of psychiatry, a co-investigator on the study, also spoke with the Enquirer.
You can read the full news release here.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
Forbes highlights UC co-op as a model for corporate America
June 3, 2026
Forbes names the University of Cincinnati as a leader in co-op and work-integrated learning, highlighting UC as a model for how higher education can prove value to employers and students.